ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mesalamine API Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-8C7614
Home | Market Reports | Business & Industrial| Chemicals Industry
Global and United States Mesalamine API Market Insights Forecast to 2027
BUY CHAPTERS

Global Mesalamine API Market Research Report 2025

Code: QYRE-Auto-8C7614
Report
July 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
PharmaZell GmbH
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Chemi SPA
Hangzhou Brother
Lianyungang Fengheng Biopharm

Mesalamine API Market Size

The global market for Mesalamine API was valued at US$ 186 million in the year 2024 and is projected to reach a revised size of US$ 239 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Mesalamine API Market

Mesalamine API Market

Mesalamine was approved for medical use in the United States in 1987. Mesalamine, also known as mesalazine or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.
With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.
Global key players of Mesalamine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalamine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mesalamine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalamine API.
The Mesalamine API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mesalamine API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesalamine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Mesalamine API Market Report

Report Metric Details
Report Name Mesalamine API Market
Accounted market size in year US$ 186 million
Forecasted market size in 2031 US$ 239 million
CAGR 3.7%
Base Year year
Forecasted years 2025 - 2031
by Type
  • Purity ≥ 97 %
  • Purity ≥ 98 %
  • Purity ≥ 99 %
by Application
Production by Region
  • North America
  • Europe
  • China
  • India
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Xinxiang Tianfeng Fine Chemical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mesalamine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Mesalamine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Mesalamine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Mesalamine API Market growing?

Ans: The Mesalamine API Market witnessing a CAGR of 3.7% during the forecast period 2025-2031.

What is the Mesalamine API Market size in 2031?

Ans: The Mesalamine API Market size in 2031 will be US$ 239 million.

What is the market share of major companies in Mesalamine API Market?

Ans: The top 3 companies hold a share over 50%.

What is the Mesalamine API Market share by region?

Ans: Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

Who are the main players in the Mesalamine API Market report?

Ans: The main players in the Mesalamine API Market are PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Xinxiang Tianfeng Fine Chemical

What are the Application segmentation covered in the Mesalamine API Market report?

Ans: The Applications covered in the Mesalamine API Market report are Tablets, Capsules, Granule, Suppository, Enema, Others

What are the Type segmentation covered in the Mesalamine API Market report?

Ans: The Types covered in the Mesalamine API Market report are Purity ≥ 97 %, Purity ≥ 98 %, Purity ≥ 99 %

Recommended Reports

IBD & Colitis Drugs

API Market Trends

Anti-Inflammatory APIs

1 Mesalamine API Market Overview
1.1 Product Definition
1.2 Mesalamine API by Type
1.2.1 Global Mesalamine API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Purity ≥ 97 %
1.2.3 Purity ≥ 98 %
1.2.4 Purity ≥ 99 %
1.3 Mesalamine API by Application
1.3.1 Global Mesalamine API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Granule
1.3.5 Suppository
1.3.6 Enema
1.3.7 Others
1.4 Global Market Growth Prospects
1.4.1 Global Mesalamine API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Mesalamine API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Mesalamine API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Mesalamine API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Mesalamine API Production Market Share by Manufacturers (2020-2025)
2.2 Global Mesalamine API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Mesalamine API, Industry Ranking, 2023 VS 2024
2.4 Global Mesalamine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Mesalamine API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Mesalamine API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Mesalamine API, Product Offered and Application
2.8 Global Key Manufacturers of Mesalamine API, Date of Enter into This Industry
2.9 Mesalamine API Market Competitive Situation and Trends
2.9.1 Mesalamine API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Mesalamine API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Mesalamine API Production by Region
3.1 Global Mesalamine API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Mesalamine API Production Value by Region (2020-2031)
3.2.1 Global Mesalamine API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Mesalamine API by Region (2026-2031)
3.3 Global Mesalamine API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Mesalamine API Production Volume by Region (2020-2031)
3.4.1 Global Mesalamine API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Mesalamine API by Region (2026-2031)
3.5 Global Mesalamine API Market Price Analysis by Region (2020-2025)
3.6 Global Mesalamine API Production and Value, Year-over-Year Growth
3.6.1 North America Mesalamine API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Mesalamine API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Mesalamine API Production Value Estimates and Forecasts (2020-2031)
3.6.4 India Mesalamine API Production Value Estimates and Forecasts (2020-2031)
4 Mesalamine API Consumption by Region
4.1 Global Mesalamine API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Mesalamine API Consumption by Region (2020-2031)
4.2.1 Global Mesalamine API Consumption by Region (2020-2025)
4.2.2 Global Mesalamine API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Mesalamine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Mesalamine API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Mesalamine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Mesalamine API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Mesalamine API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Mesalamine API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Mesalamine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Mesalamine API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Mesalamine API Production by Type (2020-2031)
5.1.1 Global Mesalamine API Production by Type (2020-2025)
5.1.2 Global Mesalamine API Production by Type (2026-2031)
5.1.3 Global Mesalamine API Production Market Share by Type (2020-2031)
5.2 Global Mesalamine API Production Value by Type (2020-2031)
5.2.1 Global Mesalamine API Production Value by Type (2020-2025)
5.2.2 Global Mesalamine API Production Value by Type (2026-2031)
5.2.3 Global Mesalamine API Production Value Market Share by Type (2020-2031)
5.3 Global Mesalamine API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Mesalamine API Production by Application (2020-2031)
6.1.1 Global Mesalamine API Production by Application (2020-2025)
6.1.2 Global Mesalamine API Production by Application (2026-2031)
6.1.3 Global Mesalamine API Production Market Share by Application (2020-2031)
6.2 Global Mesalamine API Production Value by Application (2020-2031)
6.2.1 Global Mesalamine API Production Value by Application (2020-2025)
6.2.2 Global Mesalamine API Production Value by Application (2026-2031)
6.2.3 Global Mesalamine API Production Value Market Share by Application (2020-2031)
6.3 Global Mesalamine API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 PharmaZell
7.1.1 PharmaZell Mesalamine API Company Information
7.1.2 PharmaZell Mesalamine API Product Portfolio
7.1.3 PharmaZell Mesalamine API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 PharmaZell Main Business and Markets Served
7.1.5 PharmaZell Recent Developments/Updates
7.2 Syntese A/S
7.2.1 Syntese A/S Mesalamine API Company Information
7.2.2 Syntese A/S Mesalamine API Product Portfolio
7.2.3 Syntese A/S Mesalamine API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Syntese A/S Main Business and Markets Served
7.2.5 Syntese A/S Recent Developments/Updates
7.3 Cambrex Corporation
7.3.1 Cambrex Corporation Mesalamine API Company Information
7.3.2 Cambrex Corporation Mesalamine API Product Portfolio
7.3.3 Cambrex Corporation Mesalamine API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Cambrex Corporation Main Business and Markets Served
7.3.5 Cambrex Corporation Recent Developments/Updates
7.4 Divis Laboratories
7.4.1 Divis Laboratories Mesalamine API Company Information
7.4.2 Divis Laboratories Mesalamine API Product Portfolio
7.4.3 Divis Laboratories Mesalamine API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Divis Laboratories Main Business and Markets Served
7.4.5 Divis Laboratories Recent Developments/Updates
7.5 Chemi SpA
7.5.1 Chemi SpA Mesalamine API Company Information
7.5.2 Chemi SpA Mesalamine API Product Portfolio
7.5.3 Chemi SpA Mesalamine API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Chemi SpA Main Business and Markets Served
7.5.5 Chemi SpA Recent Developments/Updates
7.6 Ipca Laboratories
7.6.1 Ipca Laboratories Mesalamine API Company Information
7.6.2 Ipca Laboratories Mesalamine API Product Portfolio
7.6.3 Ipca Laboratories Mesalamine API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Ipca Laboratories Main Business and Markets Served
7.6.5 Ipca Laboratories Recent Developments/Updates
7.7 Hangzhou Brother
7.7.1 Hangzhou Brother Mesalamine API Company Information
7.7.2 Hangzhou Brother Mesalamine API Product Portfolio
7.7.3 Hangzhou Brother Mesalamine API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Hangzhou Brother Main Business and Markets Served
7.7.5 Hangzhou Brother Recent Developments/Updates
7.8 Lianyungang Fengheng Biopharm
7.8.1 Lianyungang Fengheng Biopharm Mesalamine API Company Information
7.8.2 Lianyungang Fengheng Biopharm Mesalamine API Product Portfolio
7.8.3 Lianyungang Fengheng Biopharm Mesalamine API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Lianyungang Fengheng Biopharm Main Business and Markets Served
7.8.5 Lianyungang Fengheng Biopharm Recent Developments/Updates
7.9 Lasa Loboratory
7.9.1 Lasa Loboratory Mesalamine API Company Information
7.9.2 Lasa Loboratory Mesalamine API Product Portfolio
7.9.3 Lasa Loboratory Mesalamine API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Lasa Loboratory Main Business and Markets Served
7.9.5 Lasa Loboratory Recent Developments/Updates
7.10 Corden Pharma Bergamo
7.10.1 Corden Pharma Bergamo Mesalamine API Company Information
7.10.2 Corden Pharma Bergamo Mesalamine API Product Portfolio
7.10.3 Corden Pharma Bergamo Mesalamine API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Corden Pharma Bergamo Main Business and Markets Served
7.10.5 Corden Pharma Bergamo Recent Developments/Updates
7.11 Erregierre SpA
7.11.1 Erregierre SpA Mesalamine API Company Information
7.11.2 Erregierre SpA Mesalamine API Product Portfolio
7.11.3 Erregierre SpA Mesalamine API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Erregierre SpA Main Business and Markets Served
7.11.5 Erregierre SpA Recent Developments/Updates
7.12 CTX Lifescience
7.12.1 CTX Lifescience Mesalamine API Company Information
7.12.2 CTX Lifescience Mesalamine API Product Portfolio
7.12.3 CTX Lifescience Mesalamine API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 CTX Lifescience Main Business and Markets Served
7.12.5 CTX Lifescience Recent Developments/Updates
7.13 Ishita Active Pharma Ingredients
7.13.1 Ishita Active Pharma Ingredients Mesalamine API Company Information
7.13.2 Ishita Active Pharma Ingredients Mesalamine API Product Portfolio
7.13.3 Ishita Active Pharma Ingredients Mesalamine API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Ishita Active Pharma Ingredients Main Business and Markets Served
7.13.5 Ishita Active Pharma Ingredients Recent Developments/Updates
7.14 YC Biotech (Jiangsu)
7.14.1 YC Biotech (Jiangsu) Mesalamine API Company Information
7.14.2 YC Biotech (Jiangsu) Mesalamine API Product Portfolio
7.14.3 YC Biotech (Jiangsu) Mesalamine API Production, Value, Price and Gross Margin (2020-2025)
7.14.4 YC Biotech (Jiangsu) Main Business and Markets Served
7.14.5 YC Biotech (Jiangsu) Recent Developments/Updates
7.15 Xinxiang Tianfeng Fine Chemical
7.15.1 Xinxiang Tianfeng Fine Chemical Mesalamine API Company Information
7.15.2 Xinxiang Tianfeng Fine Chemical Mesalamine API Product Portfolio
7.15.3 Xinxiang Tianfeng Fine Chemical Mesalamine API Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Xinxiang Tianfeng Fine Chemical Main Business and Markets Served
7.15.5 Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Mesalamine API Industry Chain Analysis
8.2 Mesalamine API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Mesalamine API Production Mode & Process Analysis
8.4 Mesalamine API Sales and Marketing
8.4.1 Mesalamine API Sales Channels
8.4.2 Mesalamine API Distributors
8.5 Mesalamine API Customer Analysis
9 Mesalamine API Market Dynamics
9.1 Mesalamine API Industry Trends
9.2 Mesalamine API Market Drivers
9.3 Mesalamine API Market Challenges
9.4 Mesalamine API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
FEATURED COMPANIES
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
PharmaZell GmbH
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Chemi SPA
Hangzhou Brother
Lianyungang Fengheng Biopharm
List of Tables
 Table 1. Global Mesalamine API Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Mesalamine API Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Mesalamine API Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Mesalamine API Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Mesalamine API Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Mesalamine API Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Mesalamine API Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Mesalamine API, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Mesalamine API as of 2024)
 Table 10. Global Market Mesalamine API Average Price by Manufacturers (US$/kg) & (2020-2025)
 Table 11. Global Key Manufacturers of Mesalamine API, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Mesalamine API, Product Offered and Application
 Table 13. Global Key Manufacturers of Mesalamine API, Date of Enter into This Industry
 Table 14. Global Mesalamine API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mesalamine API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Mesalamine API Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Mesalamine API Production Value Market Share by Region (2020-2025)
 Table 19. Global Mesalamine API Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Mesalamine API Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Mesalamine API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Mesalamine API Production (Tons) by Region (2020-2025)
 Table 23. Global Mesalamine API Production Market Share by Region (2020-2025)
 Table 24. Global Mesalamine API Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Mesalamine API Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Mesalamine API Market Average Price (US$/kg) by Region (2020-2025)
 Table 27. Global Mesalamine API Market Average Price (US$/kg) by Region (2026-2031)
 Table 28. Global Mesalamine API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Mesalamine API Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Mesalamine API Consumption Market Share by Region (2020-2025)
 Table 31. Global Mesalamine API Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Mesalamine API Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Mesalamine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Mesalamine API Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Mesalamine API Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Mesalamine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Mesalamine API Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Mesalamine API Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Mesalamine API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Mesalamine API Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Mesalamine API Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Mesalamine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Mesalamine API Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Mesalamine API Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Mesalamine API Production (Tons) by Type (2020-2025)
 Table 46. Global Mesalamine API Production (Tons) by Type (2026-2031)
 Table 47. Global Mesalamine API Production Market Share by Type (2020-2025)
 Table 48. Global Mesalamine API Production Market Share by Type (2026-2031)
 Table 49. Global Mesalamine API Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Mesalamine API Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Mesalamine API Production Value Market Share by Type (2020-2025)
 Table 52. Global Mesalamine API Production Value Market Share by Type (2026-2031)
 Table 53. Global Mesalamine API Price (US$/kg) by Type (2020-2025)
 Table 54. Global Mesalamine API Price (US$/kg) by Type (2026-2031)
 Table 55. Global Mesalamine API Production (Tons) by Application (2020-2025)
 Table 56. Global Mesalamine API Production (Tons) by Application (2026-2031)
 Table 57. Global Mesalamine API Production Market Share by Application (2020-2025)
 Table 58. Global Mesalamine API Production Market Share by Application (2026-2031)
 Table 59. Global Mesalamine API Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Mesalamine API Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Mesalamine API Production Value Market Share by Application (2020-2025)
 Table 62. Global Mesalamine API Production Value Market Share by Application (2026-2031)
 Table 63. Global Mesalamine API Price (US$/kg) by Application (2020-2025)
 Table 64. Global Mesalamine API Price (US$/kg) by Application (2026-2031)
 Table 65. PharmaZell Mesalamine API Company Information
 Table 66. PharmaZell Mesalamine API Specification and Application
 Table 67. PharmaZell Mesalamine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 68. PharmaZell Main Business and Markets Served
 Table 69. PharmaZell Recent Developments/Updates
 Table 70. Syntese A/S Mesalamine API Company Information
 Table 71. Syntese A/S Mesalamine API Specification and Application
 Table 72. Syntese A/S Mesalamine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 73. Syntese A/S Main Business and Markets Served
 Table 74. Syntese A/S Recent Developments/Updates
 Table 75. Cambrex Corporation Mesalamine API Company Information
 Table 76. Cambrex Corporation Mesalamine API Specification and Application
 Table 77. Cambrex Corporation Mesalamine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 78. Cambrex Corporation Main Business and Markets Served
 Table 79. Cambrex Corporation Recent Developments/Updates
 Table 80. Divis Laboratories Mesalamine API Company Information
 Table 81. Divis Laboratories Mesalamine API Specification and Application
 Table 82. Divis Laboratories Mesalamine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 83. Divis Laboratories Main Business and Markets Served
 Table 84. Divis Laboratories Recent Developments/Updates
 Table 85. Chemi SpA Mesalamine API Company Information
 Table 86. Chemi SpA Mesalamine API Specification and Application
 Table 87. Chemi SpA Mesalamine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 88. Chemi SpA Main Business and Markets Served
 Table 89. Chemi SpA Recent Developments/Updates
 Table 90. Ipca Laboratories Mesalamine API Company Information
 Table 91. Ipca Laboratories Mesalamine API Specification and Application
 Table 92. Ipca Laboratories Mesalamine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 93. Ipca Laboratories Main Business and Markets Served
 Table 94. Ipca Laboratories Recent Developments/Updates
 Table 95. Hangzhou Brother Mesalamine API Company Information
 Table 96. Hangzhou Brother Mesalamine API Specification and Application
 Table 97. Hangzhou Brother Mesalamine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 98. Hangzhou Brother Main Business and Markets Served
 Table 99. Hangzhou Brother Recent Developments/Updates
 Table 100. Lianyungang Fengheng Biopharm Mesalamine API Company Information
 Table 101. Lianyungang Fengheng Biopharm Mesalamine API Specification and Application
 Table 102. Lianyungang Fengheng Biopharm Mesalamine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 103. Lianyungang Fengheng Biopharm Main Business and Markets Served
 Table 104. Lianyungang Fengheng Biopharm Recent Developments/Updates
 Table 105. Lasa Loboratory Mesalamine API Company Information
 Table 106. Lasa Loboratory Mesalamine API Specification and Application
 Table 107. Lasa Loboratory Mesalamine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 108. Lasa Loboratory Main Business and Markets Served
 Table 109. Lasa Loboratory Recent Developments/Updates
 Table 110. Corden Pharma Bergamo Mesalamine API Company Information
 Table 111. Corden Pharma Bergamo Mesalamine API Specification and Application
 Table 112. Corden Pharma Bergamo Mesalamine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 113. Corden Pharma Bergamo Main Business and Markets Served
 Table 114. Corden Pharma Bergamo Recent Developments/Updates
 Table 115. Erregierre SpA Mesalamine API Company Information
 Table 116. Erregierre SpA Mesalamine API Specification and Application
 Table 117. Erregierre SpA Mesalamine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 118. Erregierre SpA Main Business and Markets Served
 Table 119. Erregierre SpA Recent Developments/Updates
 Table 120. CTX Lifescience Mesalamine API Company Information
 Table 121. CTX Lifescience Mesalamine API Specification and Application
 Table 122. CTX Lifescience Mesalamine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 123. CTX Lifescience Main Business and Markets Served
 Table 124. CTX Lifescience Recent Developments/Updates
 Table 125. Ishita Active Pharma Ingredients Mesalamine API Company Information
 Table 126. Ishita Active Pharma Ingredients Mesalamine API Specification and Application
 Table 127. Ishita Active Pharma Ingredients Mesalamine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 128. Ishita Active Pharma Ingredients Main Business and Markets Served
 Table 129. Ishita Active Pharma Ingredients Recent Developments/Updates
 Table 130. YC Biotech (Jiangsu) Mesalamine API Company Information
 Table 131. YC Biotech (Jiangsu) Mesalamine API Specification and Application
 Table 132. YC Biotech (Jiangsu) Mesalamine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 133. YC Biotech (Jiangsu) Main Business and Markets Served
 Table 134. YC Biotech (Jiangsu) Recent Developments/Updates
 Table 135. Xinxiang Tianfeng Fine Chemical Mesalamine API Company Information
 Table 136. Xinxiang Tianfeng Fine Chemical Mesalamine API Specification and Application
 Table 137. Xinxiang Tianfeng Fine Chemical Mesalamine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 138. Xinxiang Tianfeng Fine Chemical Main Business and Markets Served
 Table 139. Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Mesalamine API Distributors List
 Table 143. Mesalamine API Customers List
 Table 144. Mesalamine API Market Trends
 Table 145. Mesalamine API Market Drivers
 Table 146. Mesalamine API Market Challenges
 Table 147. Mesalamine API Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mesalamine API
 Figure 2. Global Mesalamine API Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Mesalamine API Market Share by Type: 2024 VS 2031
 Figure 4. Purity ≥ 97 % Product Picture
 Figure 5. Purity ≥ 98 % Product Picture
 Figure 6. Purity ≥ 99 % Product Picture
 Figure 7. Global Mesalamine API Market Value by Application, (US$ Million) & (2020-2031)
 Figure 8. Global Mesalamine API Market Share by Application: 2024 VS 2031
 Figure 9. Tablets
 Figure 10. Capsules
 Figure 11. Granule
 Figure 12. Suppository
 Figure 13. Enema
 Figure 14. Others
 Figure 15. Global Mesalamine API Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Mesalamine API Production Value (US$ Million) & (2020-2031)
 Figure 17. Global Mesalamine API Production Capacity (Tons) & (2020-2031)
 Figure 18. Global Mesalamine API Production (Tons) & (2020-2031)
 Figure 19. Global Mesalamine API Average Price (US$/kg) & (2020-2031)
 Figure 20. Mesalamine API Report Years Considered
 Figure 21. Mesalamine API Production Share by Manufacturers in 2024
 Figure 22. Global Mesalamine API Production Value Share by Manufacturers (2024)
 Figure 23. Mesalamine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. The Global 5 and 10 Largest Players: Market Share by Mesalamine API Revenue in 2024
 Figure 25. Global Mesalamine API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 26. Global Mesalamine API Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 27. Global Mesalamine API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 28. Global Mesalamine API Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 29. North America Mesalamine API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 30. Europe Mesalamine API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 31. China Mesalamine API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 32. India Mesalamine API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 33. Global Mesalamine API Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 34. Global Mesalamine API Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 35. North America Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 36. North America Mesalamine API Consumption Market Share by Country (2020-2031)
 Figure 37. U.S. Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 38. Canada Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. Europe Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 40. Europe Mesalamine API Consumption Market Share by Country (2020-2031)
 Figure 41. Germany Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. France Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 43. U.K. Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 44. Italy Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 45. Russia Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. Asia Pacific Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 47. Asia Pacific Mesalamine API Consumption Market Share by Region (2020-2031)
 Figure 48. China Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. Japan Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. South Korea Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 51. China Taiwan Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 52. Southeast Asia Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 53. India Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. Latin America, Middle East & Africa Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 55. Latin America, Middle East & Africa Mesalamine API Consumption Market Share by Country (2020-2031)
 Figure 56. Mexico Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 57. Brazil Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 58. Turkey Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 59. GCC Countries Mesalamine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 60. Global Production Market Share of Mesalamine API by Type (2020-2031)
 Figure 61. Global Production Value Market Share of Mesalamine API by Type (2020-2031)
 Figure 62. Global Mesalamine API Price (US$/kg) by Type (2020-2031)
 Figure 63. Global Production Market Share of Mesalamine API by Application (2020-2031)
 Figure 64. Global Production Value Market Share of Mesalamine API by Application (2020-2031)
 Figure 65. Global Mesalamine API Price (US$/kg) by Application (2020-2031)
 Figure 66. Mesalamine API Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Mesalazine API Market Research Report 2025
Global Mesalazine Market Research Report 2024
Global Mesalamine Market Research Report 2024
Oral Mesalazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rectal Mesalazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
5 aminosalicylic Acid API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mesalazine Suppositories Market Research Report 2024
Mesalamine Lialda Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug for Ulcerative Colitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ulcerative Colitis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ulcerative Colitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Balsalazide Disodium Market Research Report 2025
Global Aminosalicylic Acid Preparation Market Insights Forecast to 2030
Global Sodium 4 Aminosalicylate Market Research Report 2024
Global Adalimumab Market Insights Forecast to 2030
Global Mesalazine Enteric Coated Tablets Market Research Report 2024
Vesanoid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sulfadimidine and Sodium Salt Market Research Report 2024
5 Fluorosalicylic Acid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Humira Market Insights Forecast to 2030

RELATED REPORTS

Global Nano Porous Silicon–carbon Anode Material Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0F17509
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Foam Board Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16F19834
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Copper Wires Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5U6954
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Quartz Fiber Cloth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20G17359
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions